PRESS RELEASE published on 04/24/2026 at 00:15, 5 months 8 days ago Medicure Reports Financial Results for the Year Ended December 31, 2025 and Schedules April 27, 2026 Conference Call Medicure Inc. reports financial results for the year ended December 31, 2025, with total net revenue of $28.9 million and plans a conference call on April 27, 2026 at 8:30 am Eastern Time Financial Results Conference Call Pharmaceuticals Medicure Inc. Net Revenue
BRIEF published on 04/18/2026 at 01:40, 5 months 14 days ago Medicure annonce un changement de direction Medicure Inc. Médicaments Changement De Leadership Priorités Stratégiques Marché Des États-Unis
BRIEF published on 04/18/2026 at 01:40, 5 months 14 days ago Medicure Announces Leadership Change Pharmaceuticals Strategic Priorities Medicure Inc. Leadership Change United States Market
PRESS RELEASE published on 04/18/2026 at 01:35, 5 months 14 days ago Medicure Announces Resignation of President and Chief Operating Officer Medicure Inc. announces resignation of President and COO, Dr. Neil Owens. CEO Dr. Albert D. Friesen to assume responsibilities. Company remains focused on strategic priorities for the future Pharmaceuticals Resignation Healthcare Medicure Inc. Leadership
BRIEF published on 11/19/2025 at 23:05, 10 months 12 days ago Les résultats financiers de Medicure pour le troisième trimestre 2025 reflètent une croissance du chiffre d'affaires malgré une perte nette. Marley Drug Croissance Des Revenus Perte Nette Ventes D'AGGRASTAT® Résultats Financiers De Mediure
BRIEF published on 11/19/2025 at 23:05, 10 months 12 days ago Medicure's Q3 2025 Financial Results Reflect Revenue Growth Despite Net Loss Revenue Growth Marley Drug Net Loss AGGRASTAT® Sales Medicure Financial Results
PRESS RELEASE published on 11/19/2025 at 23:00, 10 months 12 days ago Medicure Reports Financial Results for Quarter Ended September 30, 2025 Medicure Inc. reports Q3 2025 results with total net revenue of $8.2 million, an overview of financial performance and key highlights Financial Performance Medicure Inc. Net Revenue Q3 2025 Results Highlights
BRIEF published on 11/13/2025 at 23:35, 10 months 18 days ago Medicure annoncera ses résultats financiers du troisième trimestre 2025 le 20 novembre Résultats Financiers Medicure Inc. Conférence Téléphonique Produits Pharmaceutiques Américains AGGRASTAT® Et ZYPITAMAG®
BRIEF published on 11/13/2025 at 23:35, 10 months 18 days ago Medicure to Announce Q3 2025 Financial Results on November 20 Financial Results Conference Call Medicure Inc. U.S. Pharmaceuticals AGGRASTAT® And ZYPITAMAG®
PRESS RELEASE published on 11/13/2025 at 23:30, 10 months 18 days ago Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025 Medicure Inc. will present Financial Results for Q3 2025 on November 20, 2025, focusing on pharmaceutical development and commercialization in the U.S. market Financial Results Conference Call Pharmaceuticals Medicure Inc. Healthcare Products
Published on 10/02/2026 at 00:30, 3 hours 53 minutes ago Immutable Holdings Provides Corporate Update
Published on 10/01/2026 at 23:05, 5 hours 18 minutes ago Vox Royalty Expands Revolving Credit Facility Up to $150 Million and Strengthens Leadership Team
Published on 10/01/2026 at 22:00, 6 hours 23 minutes ago Golden Minerals Company Announces New Management Appointments and Resignation of Mr. Pablo Castanos
Published on 10/02/2026 at 04:05, 18 minutes ago Angel Aligner Upgrades Torque Ridges to "Pressure Points" in Europe
Published on 10/02/2026 at 00:01, 4 hours 22 minutes ago PolyPeptide publishes the invitation to its extraordinary general meeting of shareholders on 26 October 2026
Published on 10/01/2026 at 23:15, 5 hours 7 minutes ago CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies
Published on 10/01/2026 at 20:45, 7 hours 38 minutes ago Ditto Named a Product Leader in KuppingerCole Analysts Leadership Compass for Identity Verification
Published on 10/01/2026 at 20:30, 7 hours 53 minutes ago Eleving Group prices EUR 200 million senior secured bonds at 9% in private placement – EUR 25 million exchange offer to follow
Published on 10/01/2026 at 19:00, 9 hours 23 minutes ago AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 19:00, 9 hours 23 minutes ago AMA CORP PLC réduit sa structure de coûts tout en préservant les fonctions clés de XpertEye
Published on 10/01/2026 at 18:40, 9 hours 42 minutes ago Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:40, 9 hours 42 minutes ago TF1 - Déclaration mensuelle des actions et droits de vote - Septembre 2026
Published on 10/01/2026 at 18:07, 10 hours 16 minutes ago Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
